Lindsay Pino

Ight, so here’s the deal with Lindsay Pino. This woman is the real deal in biotech, no cap. She’s a co-founder and CTO at Talus Bio, a Seattle startup that’s crushing it in protein science and drug discovery. Basically, she’s all about figuring out how transcription factors work and how we can target them to fight diseases like cancer and even tackle aging. That’s some advanced stuff.

So here’s the story, Lindsay’s been in the game for over a decade. She’s got a PhD and deep roots in analytical chemistry and computational biology. She’s not just playing with labs; she’s developing tech for quantitative proteomics, which is like measuring proteins with crazy precision. Imagine being able to see how proteins interact in real time, that’s the kind of stuff she’s been building her whole career.

Jump into her process, she’s now leading the charge at Talus Bio, guiding their screening platform that’s pretty much a game changer in understanding the ‘regulome’ (that’s the whole set of regulatory elements in our DNA). She’s spearheading projects around cancer drug discovery, aging, epigenetics, spatiotemporal proteomics, basically, all the hot topics in biotech right now. And on top of that, she’s recognized as a growing star, snagging the 2024 HUPO Growing Star Award. That’s a big deal in proteomics circles.

But what really stands out is her vibe, she’s super involved in the community, active in groups like the American Society for Mass Spectrometry and HUPO. She’s not just in it for herself; she’s out here mentoring, building community, and pushing the field forward. That tells you she’s motivated by more than just tech, she cares about the people and the future of biotech.

All this tells me one thing, Lindsay’s process is about pushing the boundaries of what’s possible in biology. She’s someone who jumped into the deep end, learned the ropes, and then turned her expertise into something that could actually change lives. She’s a perfect example of what it means to start something that matters, to push through bullshit, and to stay laser-focused on the goal.

Basically, she’s a scientist turned startup boss who’s shaping the future of drug discovery. And she’s doing it with passion, smarts, and no bullshit. That’s why she’s a big deal, she’s not just chasing science, she’s making science chase her.